Premium Tegoprazan API in Pakistan: Reliable Raw Material Supply for Pharmaceutical Formulators

Product Name: Tegoprazan (Active Pharmaceutical Ingredient)

Supplier / Distributor: Morgan

Therapeutic Category: Potassium-Competitive Acid Blocker (P-CAB)

Indications: Gastroesophageal Reflux Disease (GERD), Peptic Ulcers, Helicobacter pylori Eradication

Compliance Notice: This technical data page is strictly for B2B pharmaceutical manufacturers, contract manufacturing organizations (CMOs), and analytical laboratories. The Tegoprazan distributed by Morgan is a highly purified Active Pharmaceutical Ingredient (API) intended exclusively for commercial formulation and laboratory R&D. It is not a finished drug product.

About Morgan: Morgan Chemicals (Pvt.) Ltd. is a pharmaceutical raw material trading and distribution company. We source APIs from DRAP-registered and internationally certified manufacturers and supply exclusively to licensed pharmaceutical companies, CMOs, and research facilities. We do not manufacture APIs or sell finished medicines.

Product Overview and Mechanism of Action

Tegoprazan is an advanced, orally active small-molecule Active Pharmaceutical Ingredient (API). In gastroenterological pharmacology, it is classified as a potassium-competitive acid blocker (P-CAB). For pharmaceutical companies updating their gastrointestinal portfolios, this API represents a significant therapeutic shift away from legacy proton pump inhibitors (PPIs) like omeprazole or pantoprazole.

At the cellular level, the mechanism of action for Tegoprazan is highly targeted. It functions by competitively and reversibly binding to the potassium site of the H+/K+-ATPase enzyme located in the secretory canaliculi of gastric parietal cells. By blocking this specific enzyme, the API directly halts the final step of gastric acid secretion.

Unlike traditional PPIs, which are prodrugs that require a highly acidic environment for activation and take several days to achieve maximal effect, Tegoprazan binds directly to the active proton pumps. This provides a rapid onset of action, achieving profound and sustained acid suppression shortly after the first dose. Its efficacy is also independent of meal timing.

For pharmaceutical formulation scientists, integrating this API allows for the development of superior, fast-acting therapeutics for severe acid-related disorders. In commercial manufacturing, this active ingredient is typically formulated into 50 mg oral solid tablets.

Sourcing Tegoprazan in Pakistan: Morgan’s Supply Network

Developing and commercializing next-generation gastroenterology formulations requires a highly resilient raw material pipeline. Procuring specialty P-CAB APIs for local commercial manufacturing frequently involves navigating extended lead times, rigid customs bottlenecks, and complex regulatory compliance. Sourcing Tegoprazan Pakistan through Morgan’s localized distribution network mitigates these complex supply chain risks.

Morgan sources commercial-scale and pilot-scale quantities from global manufacturing partners operating in strict adherence to ICH Q7 Good Manufacturing Practice (GMP) guidelines. Partnering with Morgan as your primary supply vendor secures several operational provisions for your manufacturing facility:

• DRAP Submission Assistance: Morgan coordinates with DRAP-registered API manufacturers to obtain and forward the necessary compliance documentation on your behalf. This includes the open part of the Drug Master File (DMF), comprehensive impurity profiles, and accelerated stability data to strictly support your Drug Regulatory Authority of Pakistan (DRAP) dossier submissions.
• Supply Chain Stability: Our localized API inventory management eliminates international transit variables. Whether you require a standard batch or are scaling up a high-volume Tegoprazan api Pakistan procurement order, we help ensure that your commercial batch schedules and production timelines are met without costly line stoppages.
• Batch-to-Batch Uniformity: Every shipment coordinated by Morgan includes a detailed Certificate of Analysis (CoA) issued by the original manufacturer. We ensure our supplied batches maintain consistent chemical purity, controlled moisture limits, and a precise particle size distribution (PSD) for predictable behavior during blending, wet granulation, and tablet compression processes.

Technical Specifications for QA & R&D

The Tegoprazan API supplied by Morgan undergoes exacting analytical testing at the source to meet current international pharmacopeial standards.

• Chemical Name: (S)-4-((5,7-difluorochroman-4-yl)oxy)-N,N,2-trimethyl-1H-benzo[d]imidazole-6-carboxamide
• CAS Number: 942195-55-3
• Appearance: White to off-white crystalline solid powder
• Molecular Formula: C20H19F2N3O3
• Molecular Weight: 387.38 g/mol
• Assay / Purity (HPLC): ≥ 99.0%
• Solubility Profile: Detailed solubility parameters across standard organic solvents and aqueous buffers are documented in the technical data sheet to assist your analytical R&D teams with dissolution profiling and pre-formulation stability studies.

Manufacturing and Handling Guidelines for Formulators

Tegoprazan is a potent gastric acid secretion inhibitor. Facilities processing this API must enforce standard occupational exposure limits (OEL) to protect personnel on the manufacturing floor.

• Storage Conditions: Store the raw API powder in securely closed, light-resistant containers. Maintain climate-controlled conditions as specified by the batch protocol (typically controlled room temperature, strictly protected from excessive heat and ambient humidity) to prevent degradation and maintain structural integrity.
• Occupational Safety: Personnel handling the pure API powder must follow advanced industrial containment protocols. Processing requires appropriate Personal Protective Equipment (PPE), including P3/N95 industrial dust masks, chemical-resistant nitrile gloves, and full protective facility garments. Dispensing, milling, and blending stages must be executed within localized exhaust ventilation systems or dedicated negative-pressure weighing booths to prevent the inhalation of airborne particulates and facility cross-contamination.

Distributor Disclaimer: Morgan Chemicals is a pharmaceutical raw material trading and distribution company. This API is sourced from DRAP-registered, GMP-certified manufacturing partners. Morgan Chemicals does not manufacture APIs, does not hold DRAP manufacturing registration, and does not sell finished medicines. This product is supplied exclusively to licensed pharmaceutical companies, CMOs, and research facilities in Pakistan — not for individual or consumer sale.